UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification

American journal of roentgenology (1976), 1994-05, Vol.162 (5), p.1067-1071

1994

Volltextzugriff (PDF)

New swedish breast cancer detection results for women aged 40–49

Cancer, 1993-08, Vol.72 (S4), p.1437-1448

1993

Volltextzugriff (PDF)

Dacryocystography: comparison of water-soluble and oil-based contrast agents

Radiology, 1989-12, Vol.173 (3), p.827-830

1989

Volltextzugriff (PDF)

Potential contribution of computer-aided detection to the sensitivity of screening mammography

Radiology, 2000-05, Vol.215 (2), p.554-562

2000

Volltextzugriff (PDF)

Standardized abnormal interpretation and cancer detection ratios to assess reading volume and reader performance in a breast screening program

Radiology, 2000-05, Vol.215 (2), p.563-567

2000

Volltextzugriff (PDF)

Xeromammographic diagnosis of carcinoma of the breast in office practice

Surgery, gynecology & obstetrics, 1987-05, Vol.164 (5), p.452

1987

Volltextzugriff (PDF)

Breast‐cancer screening with mammography in women aged 40–49 years

International journal of cancer, 1996-12, Vol.68 (6), p.693-699

Falun Meeting, Falun, Sweden, Organizing Committee and Collaborators

1996

Volltextzugriff (PDF)

Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the Screening Mammography Program of British Columbia

Breast cancer research and treatment, 1999-03, Vol.54 (1), p.73-81

1999

Volltextzugriff (PDF)

Quality-oriented mass mammography screening

Radiology, 1995-01, Vol.194 (1), p.185-188

1995

Volltextzugriff (PDF)

The Canadian National Breast Screening Study: a Canadian critique

American journal of roentgenology (1976), 1993-10, Vol.161 (4), p.761-763

1993

Volltextzugriff (PDF)

Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare

International journal of cancer, 1996-12, Vol.68 (6), p.693-699

1996

Volltextzugriff (PDF)

Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients

PloS one, 2011-12, Vol.6 (12), p.e27810

2011

Volltextzugriff (PDF)

Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populations

PloS one, 2013-07, Vol.8 (7), p.e67946

2013

Volltextzugriff (PDF)

Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients

Journal of antimicrobial chemotherapy, 2011-10, Vol.66 (10), p.2350-2361

2011

Volltextzugriff (PDF)

Is there a need to increase the dose of efavirenz during concomitant rifampicin-based antituberculosis therapy in sub-Saharan Africa? The HIV-TB pharmagene study

Pharmacogenomics, 2015-07, Vol.16 (10), p.1047-1064

2015

Volltextzugriff (PDF)

The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models

Neuro-oncology (Charlottesville, Va.), 2023-03, Vol.25 (3), p.566-579

2023

Volltextzugriff (PDF)

Long-Term Effect of Rifampicin-Based Anti-TB Regimen Coadministration on the Pharmacokinetic Parameters of Efavirenz and 8-Hydroxy-Efavirenz in Ethiopian Patients

Journal of clinical pharmacology, 2016-12, Vol.56 (12), p.1538-1549

2016

Volltextzugriff (PDF)

Invasive lobular carcinoma of the breast: mammographic characteristics and computer-aided detection

Radiology, 2002-10, Vol.225 (1), p.182-189

2002

Volltextzugriff (PDF)

High plasma efavirenz level and CYP2B66 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study

The pharmacogenomics journal, 2012-12, Vol.12 (6), p.499-506

2012

Volltextzugriff (PDF)

Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients

The pharmacogenomics journal, 2013-12, Vol.13 (6), p.484-489

2013

Volltextzugriff (PDF)

Effect of Rifampicin and CYP2B6 Genotype on Long‐Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis

Clinical pharmacology and therapeutics, 2011-09, Vol.90 (3), p.406-413

2011

Volltextzugriff (PDF)

CYP3A5 Genotype has an Impact on the Metabolism of the HIV Protease Inhibitor Saquinavir

Clinical pharmacology and therapeutics, 2007-05, Vol.81 (5), p.708-712

2007

Volltextzugriff (PDF)

Comparison of the antiarrhythmic potential of doxapram and its metabolite ketodoxaparam

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection

Journal of hepatology, 2018-04, Vol.68, p.S3

2018

Volltextzugriff (PDF)

GS-005 - Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection

Journal of hepatology, 2018-04, Vol.68, p.S3-S3

2018

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(32)
Tagungsberichte
(1)

Sprache

Englisch
(33)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Humans
(24)
Science & Technology
(24)
Female
(22)
Life Sciences & Biomedicine
(22)
Adult
(17)
Middle Aged
(16)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Male
(12)
Medicin Och Hälsovetenskap
(11)
Radiology, Nuclear Medicine & Medical Imaging
(10)
Hiv Infections - Drug Therapy
(8)
Aged
(7)
Gynecology. Andrology. Obstetrics
(7)
Mammary Gland Diseases
(7)
Pharmacology & Pharmacy
(7)
Tumors
(7)
Efavirenz
(6)
Genotype
(6)
Prospective Studies
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification

New swedish breast cancer detection results for women aged 40–49

Dacryocystography: comparison of water-soluble and oil-based contrast agents

Potential contribution of computer-aided detection to the sensitivity of screening mammography

Standardized abnormal interpretation and cancer detection ratios to assess reading volume and reader performance in a breast screening program

Xeromammographic diagnosis of carcinoma of the breast in office practice

Breast‐cancer screening with mammography in women aged 40–49 years

Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the Screening Mammography Program of British Columbia

Quality-oriented mass mammography screening

The Canadian National Breast Screening Study: a Canadian critique

Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare

Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients

Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populations

Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients

Is there a need to increase the dose of efavirenz during concomitant rifampicin-based antituberculosis therapy in sub-Saharan Africa? The HIV-TB pharmagene study

The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models

Long-Term Effect of Rifampicin-Based Anti-TB Regimen Coadministration on the Pharmacokinetic Parameters of Efavirenz and 8-Hydroxy-Efavirenz in Ethiopian Patients

Invasive lobular carcinoma of the breast: mammographic characteristics and computer-aided detection

High plasma efavirenz level and CYP2B66 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study

Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients

Effect of Rifampicin and CYP2B6 Genotype on Long‐Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis

CYP3A5 Genotype has an Impact on the Metabolism of the HIV Protease Inhibitor Saquinavir

Comparison of the antiarrhythmic potential of doxapram and its metabolite ketodoxaparam

Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection

GS-005 - Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection

Suchergebnisse filtern